Pacira | PCRX - 现金及等价物

金融业

USD

USD 1.21B

现金及等价物

USD 144.31M

USD 50.74M

USD 514.96M

USD 108.79M

USD 367.66M

USD 4.63M

USD 40.24M

790

EPS每股收益

USD 0.6

股本和储备

USD 653.89M

USD 126.64M

债务利息支出

USD 3.7M

USD 2.3M

USD 367.66M

USD 1.06B

USD 2.92M

USD 172.75M

USD 4.63M

普通股股本

USD 39.31M

38.58

USD 571K

USD 177M

销售和管理费用

USD 83.88M

USD 150.37M

贸易债权人

USD 14.01M

应收帐款人

USD 125.64M

	现金及等价物	更改		日
Assertio Holdings	USD 38.5M		8.59M	2025-09
Astellas Pharma	JPY 188.37B		8.51B	2025-03
Bristol-Myers Squibb	USD 9.57B		635M	2026-03
Cara Therapeutics	USD 20.73M		684K	2025-12
Coherus Biosciences	USD 88.88M		14.47M	2025-12
Heron Therapeutics	USD 26.12M		2.53M	2026-03
Ironwood Pharmaceuticals	USD 220.47M		5.01M	2026-03
J&J	USD 21.69B		1.98B	2026-03
Ligand Pharmaceuticals	USD 115.08M		59.85M	2026-03
Nektar Therapeutics	USD 15.12M		25.92M	2025-12
Novo Nordisk A/S	DKK 18.44B		5.78B	2025-06
Omeros	USD 1.9M		2.36M	2025-06
Pacira	USD 144.31M		14.24M	2026-03
Perrigo	USD 531.6M		99.5M	2025-12
Pfizer	USD 1.7B		561M	2026-03
Supernus Pharmaceuticals	USD 184.87M		56.42M	2026-03
Teva Pharmaceutical Industries	USD 3.56B		1.35B	2025-12
Xeris Pharmaceuticals	USD 111.75M		708K	2026-03
Xoma	USD 143.9M		7.68M	2024-06
Zoetis	USD 1.94B		369M	2026-03